FDA Advisory Committee Votes Favoring Pfizer’s COVID-19 Pill Paxlovid – Pfizer (NYSE:PFE)
The FDA’s Antimicrobial Drugs Advisory Committee voted 16-1 that available data support the safety and effectiveness of Pfizer Inc’s PFE Paxlovid for mild-to-moderate COVID-19 in adult patients who are at high risk for…